Skip to the page

Data / Form D filings / Nanochon, Inc.

Nanochon, Inc.: Form D filings

Nanochon, Inc., a biotechnology company in Washington, DC, filed 4 Form D notices with the SEC between 2021 and 2026. The latest, on February 5, 2026, reports $3.6 million sold of a $4.2 million offering to 39 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1317 SHEPHERD ST NW UNIT D, Washington, DC, 20011
Phone
(703) 994-6099
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1885962

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 5, 2026New notice$4,223,097$3,582,315$640,78239Dec 24, 2025sec.gov
May 15, 2024Amendment$6,000,000$3,991,279$2,008,72134Aug 15, 2023sec.gov
Aug 28, 2023New notice$3,500,000$1,801,281$1,698,71925Aug 15, 2023sec.gov
Oct 1, 2021New notice$2,500,000$2,005,998$494,00217Sep 16, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Benjamin HolmesExecutive Officer, Director
Robert CreedenDirector
Sean ChurchillDirector
Nick PachudaDirector
Kurt JacobusDirector

Other biotechnology companies in District of Columbia that filed recently

Every Form D from the week of Feb 2, 2026 · All recent filings in District of Columbia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Nanochon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.